Literature DB >> 18438631

[Malignant melanoma of the lacrimal sac].

L M Heindl1, B Schick, E Kämpgen, F E Kruse, L M Holbach.   

Abstract

A 68-year-old woman presented with a 10-month history of right-sided epiphora, bloody tears, and medial canthal mass. Computed tomography revealed a soft tissue mass of the right lacrimal sac with widening of the bony nasolacrimal canal. External dacryocystorhinostomy with incisional biopsy confirmed the diagnosis of malignant melanoma. After staging, further therapy included orbital exenteration, lateral rhinotomy with en bloc resection of the lacrimal drainage apparatus, and adjuvant radioimmunotherapy. One year after surgery, no evidence of local recurrence or metastatic disease could be detected.

Entities:  

Mesh:

Year:  2008        PMID: 18438631     DOI: 10.1007/s00347-008-1740-0

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  6 in total

Review 1.  Malignant melanoma of the lacrimal sac.

Authors:  R M Owens; M K Wax; D Kostik; J V Linberg; J Hogg
Journal:  Otolaryngol Head Neck Surg       Date:  1995-11       Impact factor: 3.497

2.  Prognostic factors in primary malignant melanoma of the conjunctiva: a clinicopathological study of 256 cases.

Authors:  A D Paridaens; D C Minassian; A C McCartney; J L Hungerford
Journal:  Br J Ophthalmol       Date:  1994-04       Impact factor: 4.638

3.  Management of lacrimal sac tumours.

Authors:  D N Parmar; G E Rose
Journal:  Eye (Lond)       Date:  2003-07       Impact factor: 3.775

4.  Nonepithelial tumors of the lacrimal sac.

Authors:  J J Pe'er; M Stefanyszyn; A A Hidayat
Journal:  Am J Ophthalmol       Date:  1994-11-15       Impact factor: 5.258

Review 5.  Lacrimal sac tumors.

Authors:  M A Stefanyszyn; A A Hidayat; J J Pe'er; J C Flanagan
Journal:  Ophthalmic Plast Reconstr Surg       Date:  1994-09       Impact factor: 1.746

6.  Mucosal melanoma of the head and neck.

Authors:  D J Hoyt; T Jordan; S R Fisher
Journal:  Arch Otolaryngol Head Neck Surg       Date:  1989-09
  6 in total
  9 in total

1.  [Selective lacrimal sac biopsy for external dacryocystorhinostomy: a clinical pathological study].

Authors:  L M Heindl; E Treutlein; A G M Jünemann; F E Kruse; L M Holbach
Journal:  Ophthalmologe       Date:  2010-12       Impact factor: 1.059

Review 2.  [Significance of transcanalicular laser assisted dacryocystorhinostomy in modern lacrimal drainage surgery].

Authors:  K R Koch; H Kühner; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2015-02       Impact factor: 1.059

Review 3.  [Minimally invasive bypass surgery for nasolacrimal duct obstruction : Transcanalicular laser-assisted dacryocystorhinostomy].

Authors:  K R Koch; C Cursiefen; L M Heindl
Journal:  Ophthalmologe       Date:  2017-05       Impact factor: 1.059

4.  [Malignant neoplasms of the lacrimal sac: rarity among tear duct diseases].

Authors:  E Bertelmann; S Pahl; P Rieck
Journal:  Ophthalmologe       Date:  2011-05       Impact factor: 1.059

5.  Primary malignant melanoma of the lacrimal sac.

Authors:  Yang-Jun Li; Shao-Jun Zhu; Hong Yan; Jing Han; Dan Wang; Shuang Xu
Journal:  BMJ Case Rep       Date:  2012-08-13

Review 6.  [Tumors of the lacrimal drainage system].

Authors:  C von Goscinski; K R Koch; C Cursiefen; L M Heindl
Journal:  HNO       Date:  2016-06       Impact factor: 1.284

Review 7.  CT and MRI findings in relapsing primary malignant melanoma of the lacrimal sac: a case report and brief literature review.

Authors:  Ju-Wei Shao; Jian-Hua Yin; Shu-Tian Xiang; Qian He; Hong Zhou; Wei Su
Journal:  BMC Ophthalmol       Date:  2020-05-14       Impact factor: 2.209

8.  Lacrimal Sac Malignant Melanoma in 15 Japanese Patients: Case Report and Literature Review.

Authors:  Toshihiko Matsuo; Takehiro Tanaka; Osamu Yamasaki
Journal:  J Investig Med High Impact Case Rep       Date:  2019 Jan-Dec

9.  Comparison of Clinical Features and Treatment Outcome in Benign and Malignant Lacrimal Sac Tumors.

Authors:  Che-Yuan Kuo; Chieh-Chih Tsai; Shu-Ching Kao; Wen-Ming Hsu; Catherine Jui-Ling Liu
Journal:  Biomed Res Int       Date:  2020-01-31       Impact factor: 3.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.